Published in

Elsevier, European Journal of Cancer, 7(48), p. 1023-1030

DOI: 10.1016/j.ejca.2012.02.048

Links

Tools

Export citation

Search in Google Scholar

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma

Journal article published in 2012 by Christoph Seidel, Jonas Busch, Steffen Weikert, Sandra Steffens, Martin Fenner ORCID, Arnold Ganser, Viktor Grünwald
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO